Leef Brands (LEEEF) Total Non-Current Liabilities (2023 - 2026)
Leef Brands (LEEEF) reported Total Non-Current Liabilities of $36.1 million for Q1 2026, up 0.86% sequentially from $35.8 million in Q4 2025.
Leef Brands (LEEEF) Total Non-Current Liabilities (2023 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 4 years of Total Non-Current Liabilities data on file, last reported at $36.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Non-Current Liabilities changed N/A year-over-year to $36.1 million; the trailing twelve-month figure through Mar 2026 stood at $36.1 million (changed N/A YoY), and the FY2025 full-year result was $35.8 million, down 22.9% from the prior year.
- Total Non-Current Liabilities rose to $36.1 million in Q1 2026, from $35.8 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $46.4 million in Q4 2024 to a low of -$1.1 million in Q4 2023.
- A 4-year average of $29.3 million and a median of $35.9 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities jumped 4340.37% in 2024 and fell 22.9% in 2025, its largest moves.
- Tracing LEEEF's Total Non-Current Liabilities over 4 years: stood at -$1.1 million in 2023, then jumped by 4340.37% to $46.4 million in 2024, then fell by 22.9% to $35.8 million in 2025, then rose by 0.86% to $36.1 million in 2026.
- Business Quant data shows LEEEF's Total Non-Current Liabilities at $36.1 million in Q1 2026, $35.8 million in Q4 2025, and $46.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 14.92 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 18.28 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 33.47 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 20.09 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.24 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.26 Bn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | 36.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.08 Mn |
| Dec 31, 2025 | 35.78 Mn |
| Dec 31, 2024 | 46.40 Mn |
| Dec 31, 2023 | -1.09 Mn |